Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma

Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma

10.1186/s40164-020-00164-4

Saved in:

Bibliographic Details
Main Authors:	Zhang, X.Y., Rajagopalan, D., Chung, T.-H., Hooi, L., Toh, T.B., Tian, J.S., Rashid, M.B.M.A., Sahib, N.R.B.M., Gu, M., Lim, J.J., Wang, W., Chng, W.J., Jha, S., Chow, E.K.-H.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	BioMed Central Ltd. 2021
Subjects:	G9a Multiple myeloma NF-?B pathway Proliferation RelB Therapeutic target Tumorigenesis
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/198801
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

IDENTIFICATION OF G9A AS A THERAPEUTICALLY TARGETABLE DRIVER OF MULTIPLE MYELOMA TUMORIGENESIS
by: ZHANG XIYUN
Published: (2020)

EZH2 and NF-KB Crosstalk in Breast Cancer
by: LEE SHUET THENG
Published: (2012)

Targeting nf-κb signaling for multiple myeloma
by: Wong, A.H.-H., et al.
Published: (2021)

Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
by: Kannaiyan, R., et al.
Published: (2014)

IDENTIFICATION OF A NOVEL AGENT THAT CAN SUPPRESS PROLIFERATION, INDUCE APOPTOSIS AND OVERCOME CHEMORESISTANCE IN MULTIPLE MYELOMA
by: RADHAMANI KANNAIYAN
Published: (2014)

MOLECULAR CHARACTERIZATION OF GREB1 AND TRAF3 IN THE ONCOGENIC SIGNALLING PATHWAYS OF HUMAN CANCER
by: SULTAN ABDA NEJA
Published: (2019)

SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer
by: Long, L, et al.
Published: (2020)

Formononetin regulates multiple oncogenic signaling cascades and enhances sensitivity to bortezomib in a multiple myeloma mouse model
by: Kim, C., et al.
Published: (2021)

Centrosomes and myeloma; aneuploidy and proliferation
by: Chng, W.J., et al.
Published: (2016)

The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network
by: Tan, D., et al.
Published: (2016)

The role of NF-kB and histone deacetylase in gene regulation
by: CHEW SOO FEN, JOANNE CHRISTABELLE
Published: (2010)

Natural history and prognostic factors at first relapse in multiple myeloma
by: Wang, C., et al.
Published: (2021)

Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils
by: Sun, J., et al.
Published: (2011)

The Role of Serum Amyloid A in atherosclerosis
by: TAN SI ZHEN
Published: (2012)

Thioredoxin-like 6 protects retinal cell line from photooxidative damage by upregulating NF-κB activity
by: Wang, X.W., et al.
Published: (2014)

Thioredoxin-like 6 protects retinal cell line from photooxidative damage by upregulating NF-κB activity
by: Wang, X.W., et al.
Published: (2011)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
by: Davies, FE, et al.
Published: (2023)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
by: Davies, FE, et al.
Published: (2023)

Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells
by: Somu, C., et al.
Published: (2021)

Fangchinoline, a bisbenzylisoquinoline alkaloid can modulate cytokine-impelled apoptosis via the dual regulation of NF-?B and AP-1 pathways
by: Jung, Y.Y., et al.
Published: (2021)

The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: An analysis of the Singapore multiple myeloma study group
by: Tan, D., et al.
Published: (2016)

Effect of mitogen-activated protein kinases on chemokine synthesis induced by substance P in mouse pancreatic acinar cells
by: Ramnath, R.D., et al.
Published: (2011)

Extramedullary plasmacytoma of the orbit as initial presentation of multiple myeloma
by: Razak, R.A., et al.
Published: (2016)

Key cell signaling pathways modulated by zerumbone: Role in the prevention and treatment of cancer
by: Prasannan, R., et al.
Published: (2014)

Role of NF-κB in tumorigenesis
by: Shanmugam, M.K., et al.
Published: (2014)

The Molecular Biology of Multiple Myeloma
by: Chng, W.J., et al.
Published: (2016)

Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation
by: Won, M., et al.
Published: (2014)

HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis
by: Bi, Xuezhi, et al.
Published: (2018)

Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-B: Implication in breast cancer metastasis
by: Bist, P., et al.
Published: (2014)

Porcine circovirus type 2 induces the activation of nuclear factor kappa B by IκBα degradation
by: Wei, L., et al.
Published: (2011)

Porcine circovirus type 2 induces the activation of nuclear factor kappa B by IκBα degradation
by: Wei, L., et al.
Published: (2016)

Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
by: Chng, W.-J., et al.
Published: (2014)

NF-κB signaling in neurite growth and neuronal survival
by: Yu, F., et al.
Published: (2014)

Anti-inflammatory effects of inhibitors of the NF-kB pathway in the mouse asthma model
by: BAO ZHANG
Published: (2010)

SUPEROXIDE-MEDIATED ACTIVATION OF NF-kB SIGNALLING VIA REDOX-MEDIATED PP2A INACTIVATION
by: YEE YI HUI
Published: (2020)

Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy
by: Li, F., et al.
Published: (2011)

RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines
by: Naidu, V.G.M., et al.
Published: (2014)

Qualitative study of factors affecting patient, caregiver and physician preferences for treatment of myeloma and indolent lymphoma
by: Jen, W.-Y., et al.
Published: (2021)

Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells
by: Shi, R.-X., et al.
Published: (2014)

Chrysin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB
by: Li, X., et al.
Published: (2011)